BAX (Baxter International) Total Stockholders Equity: $6,043 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BAX Baxter International Inc BAX
60 GF Score
Price $23.34
GF Value $34.41
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Baxter International Total Stockholders Equity?

Baxter International BAX +4.20% 60 Total Stockholders Equity is $6,043 Mil as of Mar. 2026. GuruFocus rates BAX with a GF Score™ of 60/100 and a GF Value™ of $34.41 (Possible Value Trap). The stock has 9 warning signs investors should review.

Baxter International's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $6,043 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Baxter International's Book Value per Share for the quarter that ended in Mar. 2026 was $11.70. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Baxter International's Debt-to-Equity for the quarter that ended in Mar. 2026 was 1.60.

Baxter International  (NYSE:BAX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Baxter International's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6043-0)/516.447
=11.70

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Baxter International's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(842 + 8845) / 6043
=1.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Total Stockholders Equity Related Terms

Baxter International Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Baxter International's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Total Stockholders Equity Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,077.00 5,833.00 8,402.00 6,964.00 6,129.00

Baxter International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,081.00 7,320.00 7,241.00 6,129.00 6,043.00
BAX
60GF Score
Baxter International Inc BAX
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $6,043 Mil mean?
Baxter International (BAX) has a Total Stockholders Equity of $6,043 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Baxter International and its competitors.
Is Baxter International's Total Stockholders Equity too high?
Baxter International's current Total Stockholders Equity is $6,043 Mil. Overall, Baxter International has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Total Stockholders Equity compare to ALGN and SOLV?
Baxter International's Total Stockholders Equity of $6,043 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Baxter International and its competitors. Baxter International's current Total Stockholders Equity is $6,043 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BAX) is currently considered Possible Value Trap. The stock's GF Value™ is $34.41, compared to a current price of $23.34 — trading 32.2% below its estimated fair value. The current Total Stockholders Equity is $6,043 Mil. Baxter International's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Baxter International (BAX), the current Total Stockholders Equity is $6,043 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (BAX) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of $23.34 is trading 32.2% below its estimated GF Value™ of $34.41. GuruFocus considers Baxter International to be Possible Value Trap.

Key valuation signals for BAX:

  • Total Stockholders Equity: $6,043 Mil
  • GF Value™: $34.41 vs. price of $23.34 (32.2% below fair value)
  • GF Score™: 60/100 with 9 warning signs

No single metric tells the full story. See the BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
60GF Score

Get the complete analysis for BAX

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.34
Price
$34.41
GF Value